Logo image of AQNB

ALGONQUIN PWR & UTILITY - AQNCN 8.5321 07/01/2079 (AQNB) Stock Fundamental Analysis

USA - New York Stock Exchange - NYSE:AQNB - US0158578080

25.595 USD
+0.02 (+0.08%)
Last: 1/15/2026, 8:04:00 PM
Fundamental Rating

3

Taking everything into account, AQNB scores 3 out of 10 in our fundamental rating. AQNB was compared to 26 industry peers in the Multi-Utilities industry. While AQNB seems to be doing ok healthwise, there are quite some concerns on its profitability. AQNB does not seem to be growing, but still is valued expensively.


Dividend Valuation Growth Profitability Health

3

1. Profitability

1.1 Basic Checks

  • AQNB had positive earnings in the past year.
  • AQNB had a positive operating cash flow in the past year.
  • The reported net income has been mixed in the past 5 years: AQNB reported negative net income in multiple years.
  • Each year in the past 5 years AQNB had a positive operating cash flow.
AQNB Yearly Net Income VS EBIT VS OCF VS FCFAQNB Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 500M -500M -1B

1.2 Ratios

  • AQNB has a worse Return On Assets (-0.27%) than 96.15% of its industry peers.
  • AQNB has a Return On Equity of -0.80%. This is amonst the worse of the industry: AQNB underperforms 96.15% of its industry peers.
  • AQNB's Return On Invested Capital of 3.16% is on the low side compared to the rest of the industry. AQNB is outperformed by 88.46% of its industry peers.
  • The Average Return On Invested Capital over the past 3 years for AQNB is in line with the industry average of 3.94%.
  • The 3 year average ROIC (2.36%) for AQNB is below the current ROIC(3.16%), indicating increased profibility in the last year.
Industry RankSector Rank
ROA -0.27%
ROE -0.8%
ROIC 3.16%
ROA(3y)-3.11%
ROA(5y)-0.39%
ROE(3y)-11.12%
ROE(5y)-2.83%
ROIC(3y)2.36%
ROIC(5y)2.31%
AQNB Yearly ROA, ROE, ROICAQNB Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10 -10 -20

1.3 Margins

  • The Operating Margin of AQNB (21.55%) is comparable to the rest of the industry.
  • AQNB's Operating Margin has declined in the last couple of years.
  • With a decent Gross Margin value of 73.94%, AQNB is doing good in the industry, outperforming 73.08% of the companies in the same industry.
  • AQNB's Gross Margin has been stable in the last couple of years.
Industry RankSector Rank
OM 21.55%
PM (TTM) N/A
GM 73.94%
OM growth 3Y3.93%
OM growth 5Y-3.09%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y1.98%
GM growth 5Y0.16%
AQNB Yearly Profit, Operating, Gross MarginsAQNB Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 -20 40 -40 60

4

2. Health

2.1 Basic Checks

  • The Return on Invested Capital (ROIC) is below the Cost of Capital (WACC), so AQNB is destroying value.
  • AQNB has more shares outstanding than it did 1 year ago.
  • AQNB has more shares outstanding than it did 5 years ago.
  • AQNB has a better debt/assets ratio than last year.
AQNB Yearly Shares OutstandingAQNB Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M
AQNB Yearly Total Debt VS Total AssetsAQNB Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 5B 10B 15B

2.2 Solvency

  • AQNB has an Altman-Z score of 1.31. This is a bad value and indicates that AQNB is not financially healthy and even has some risk of bankruptcy.
  • AQNB has a Altman-Z score of 1.31. This is amongst the best in the industry. AQNB outperforms 96.15% of its industry peers.
  • A Debt/Equity ratio of 1.33 is on the high side and indicates that AQNB has dependencies on debt financing.
  • AQNB has a better Debt to Equity ratio (1.33) than 61.54% of its industry peers.
Industry RankSector Rank
Debt/Equity 1.33
Debt/FCF N/A
Altman-Z 1.31
ROIC/WACC0.46
WACC6.89%
AQNB Yearly LT Debt VS Equity VS FCFAQNB Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 2B 4B 6B

2.3 Liquidity

  • AQNB has a Current Ratio of 1.23. This is a normal value and indicates that AQNB is financially healthy and should not expect problems in meeting its short term obligations.
  • AQNB has a better Current ratio (1.23) than 88.46% of its industry peers.
  • AQNB has a Quick Ratio of 1.03. This is a normal value and indicates that AQNB is financially healthy and should not expect problems in meeting its short term obligations.
  • AQNB has a Quick ratio of 1.03. This is amongst the best in the industry. AQNB outperforms 88.46% of its industry peers.
Industry RankSector Rank
Current Ratio 1.23
Quick Ratio 1.03
AQNB Yearly Current Assets VS Current LiabilitesAQNB Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 500M 1B 1.5B

3

3. Growth

3.1 Past

  • The earnings per share for AQNB have decreased strongly by -29.79% in the last year.
  • AQNB shows a very negative growth in Earnings Per Share. Measured over the last years, the EPS has been decreasing by -10.38% yearly.
  • AQNB shows a very negative growth in Revenue. In the last year, the Revenue has decreased by -23.92%.
  • AQNB shows a small growth in Revenue. Measured over the last years, the Revenue has been growing by 7.38% yearly.
EPS 1Y (TTM)-29.79%
EPS 3Y-19.53%
EPS 5Y-10.38%
EPS Q2Q%12.5%
Revenue 1Y (TTM)-23.92%
Revenue growth 3Y0.49%
Revenue growth 5Y7.38%
Sales Q2Q%1.66%

3.2 Future

  • Based on estimates for the next years, AQNB will show a small growth in Earnings Per Share. The EPS will grow by 4.09% on average per year.
  • AQNB is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 2.30% yearly.
EPS Next Y-12.26%
EPS Next 2Y-0.48%
EPS Next 3Y6.43%
EPS Next 5Y4.09%
Revenue Next Year-9.53%
Revenue Next 2Y-3.01%
Revenue Next 3Y-0.37%
Revenue Next 5Y2.3%

3.3 Evolution

  • When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
  • When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
AQNB Yearly Revenue VS EstimatesAQNB Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 500M 1B 1.5B 2B 2.5B
AQNB Yearly EPS VS EstimatesAQNB Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 0.2 0.4 0.6

0

4. Valuation

4.1 Price/Earnings Ratio

  • A Price/Earnings ratio of 77.56 indicates a quite expensive valuation of AQNB.
  • Compared to the rest of the industry, the Price/Earnings ratio of AQNB indicates a rather expensive valuation: AQNB more expensive than 96.15% of the companies listed in the same industry.
  • AQNB's Price/Earnings ratio indicates a rather expensive valuation when compared to the S&P500 average which is at 27.54.
  • With a Price/Forward Earnings ratio of 69.84, AQNB can be considered very expensive at the moment.
  • AQNB's Price/Forward Earnings ratio is rather expensive when compared to the industry. AQNB is more expensive than 96.15% of the companies in the same industry.
  • When comparing the Price/Forward Earnings ratio of AQNB to the average of the S&P500 Index (24.31), we can say AQNB is valued expensively.
Industry RankSector Rank
PE 77.56
Fwd PE 69.84
AQNB Price Earnings VS Forward Price EarningsAQNB Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 20 40 60

4.2 Price Multiples

  • Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of AQNB indicates a rather expensive valuation: AQNB more expensive than 96.15% of the companies listed in the same industry.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 28.57
AQNB Per share dataAQNB EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 2 4 6

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y-0.48%
EPS Next 3Y6.43%

6

5. Dividend

5.1 Amount

  • AQNB has a Yearly Dividend Yield of 4.21%, which is a nice return.
  • Compared to an average industry Dividend Yield of 4.11, AQNB pays a bit more dividend than its industry peers.
  • Compared to an average S&P500 Dividend Yield of 1.92, AQNB pays a better dividend.
Industry RankSector Rank
Dividend Yield 4.21%

5.2 History

  • The dividend of AQNB has a limited annual growth rate of 0.06%.
  • AQNB has been paying a dividend for over 5 years, so it has already some track record.
  • AQNB has not decreased its dividend in the last 3 years.
Dividend Growth(5Y)0.06%
Div Incr Years1
Div Non Decr Years4
AQNB Yearly Dividends per shareAQNB Yearly Dividends per shareYearly Dividends per share 2020 2021 2022 2023 2024 2025 0.5 1 1.5 2

5.3 Sustainability

  • The earnings of AQNB are negative and hence is the payout ratio. AQNB will probably not be able to sustain this dividend level.
  • The dividend of AQNB is growing, but earnings are growing more, so the dividend growth is sustainable.
DP-569.86%
EPS Next 2Y-0.48%
EPS Next 3Y6.43%
AQNB Yearly Income VS Free CF VS DividendAQNB Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 500M -500M -1B

25.595

+0.02 (+0.08%)

Chartmill FA Rating
GICS SectorUtilities
GICS IndustryGroupUtilities
GICS IndustryMulti-Utilities
Earnings (Last)11-07
Earnings (Next)03-05
Inst Owners74.14%
Inst Owner ChangeN/A
Ins Owners0.05%
Ins Owner ChangeN/A
Market Cap19.66B
Revenue(TTM)2.39B
Net Income(TTM)-37.22M
Analysts68.33
Price Target20.92 (-18.27%)
Short Float %0%
Short Ratio2.49
Dividend
Industry RankSector Rank
Dividend Yield 4.21%
Yearly Dividend0.41
Dividend Growth(5Y)0.06%
DP-569.86%
Div Incr Years1
Div Non Decr Years4
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)17.46%
Min EPS beat(2)-0.69%
Max EPS beat(2)35.61%
EPS beat(4)2
Avg EPS beat(4)12.84%
Min EPS beat(4)-25.74%
Max EPS beat(4)42.17%
EPS beat(8)4
Avg EPS beat(8)5.61%
EPS beat(12)5
Avg EPS beat(12)1.98%
EPS beat(16)6
Avg EPS beat(16)-0.66%
Revenue beat(2)1
Avg Revenue beat(2)-0.52%
Min Revenue beat(2)-1.85%
Max Revenue beat(2)0.82%
Revenue beat(4)2
Avg Revenue beat(4)-0.08%
Min Revenue beat(4)-4.61%
Max Revenue beat(4)5.31%
Revenue beat(8)3
Avg Revenue beat(8)-1.75%
Revenue beat(12)6
Avg Revenue beat(12)-0.49%
Revenue beat(16)9
Avg Revenue beat(16)0.59%
PT rev (1m)-5.17%
PT rev (3m)-7.21%
EPS NQ rev (1m)-9.38%
EPS NQ rev (3m)-24.82%
EPS NY rev (1m)0%
EPS NY rev (3m)3.21%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-3.47%
Revenue NY rev (1m)0%
Revenue NY rev (3m)1.25%
Valuation
Industry RankSector Rank
PE 77.56
Fwd PE 69.84
P/S 8.24
P/FCF N/A
P/OCF 42.22
P/B 4.23
P/tB 6.03
EV/EBITDA 28.57
EPS(TTM)0.33
EY1.29%
EPS(NY)0.37
Fwd EY1.43%
FCF(TTM)-0.47
FCFYN/A
OCF(TTM)0.61
OCFY2.37%
SpS3.11
BVpS6.04
TBVpS4.24
PEG (NY)N/A
PEG (5Y)N/A
Graham Number6.7
Profitability
Industry RankSector Rank
ROA -0.27%
ROE -0.8%
ROCE 4%
ROIC 3.16%
ROICexc 3.18%
ROICexgc 3.56%
OM 21.55%
PM (TTM) N/A
GM 73.94%
FCFM N/A
ROA(3y)-3.11%
ROA(5y)-0.39%
ROE(3y)-11.12%
ROE(5y)-2.83%
ROIC(3y)2.36%
ROIC(5y)2.31%
ROICexc(3y)2.37%
ROICexc(5y)2.33%
ROICexgc(3y)2.6%
ROICexgc(5y)2.56%
ROCE(3y)2.99%
ROCE(5y)2.93%
ROICexgc growth 3Y4.3%
ROICexgc growth 5Y-5.03%
ROICexc growth 3Y4.14%
ROICexc growth 5Y-4.63%
OM growth 3Y3.93%
OM growth 5Y-3.09%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y1.98%
GM growth 5Y0.16%
F-Score4
Asset Turnover0.17
Health
Industry RankSector Rank
Debt/Equity 1.33
Debt/FCF N/A
Debt/EBITDA 6.76
Cap/Depr 208.02%
Cap/Sales 34.55%
Interest Coverage 1.49
Cash Conversion 51.11%
Profit Quality N/A
Current Ratio 1.23
Quick Ratio 1.03
Altman-Z 1.31
F-Score4
WACC6.89%
ROIC/WACC0.46
Cap/Depr(3y)213.94%
Cap/Depr(5y)245.17%
Cap/Sales(3y)39.89%
Cap/Sales(5y)45.08%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-29.79%
EPS 3Y-19.53%
EPS 5Y-10.38%
EPS Q2Q%12.5%
EPS Next Y-12.26%
EPS Next 2Y-0.48%
EPS Next 3Y6.43%
EPS Next 5Y4.09%
Revenue 1Y (TTM)-23.92%
Revenue growth 3Y0.49%
Revenue growth 5Y7.38%
Sales Q2Q%1.66%
Revenue Next Year-9.53%
Revenue Next 2Y-3.01%
Revenue Next 3Y-0.37%
Revenue Next 5Y2.3%
EBIT growth 1Y-15.87%
EBIT growth 3Y4.45%
EBIT growth 5Y4.06%
EBIT Next Year48.7%
EBIT Next 3Y21.37%
EBIT Next 5YN/A
FCF growth 1Y-47.31%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-27.45%
OCF growth 3Y45.17%
OCF growth 5Y-4.65%

ALGONQUIN PWR & UTILITY - AQNCN 8.5321 07/01/2079 / AQNB FAQ

Can you provide the ChartMill fundamental rating for ALGONQUIN PWR & UTILITY - AQNCN 8.5321 07/01/2079?

ChartMill assigns a fundamental rating of 3 / 10 to AQNB.


What is the valuation status of ALGONQUIN PWR & UTILITY - AQNCN 8.5321 07/01/2079 (AQNB) stock?

ChartMill assigns a valuation rating of 0 / 10 to ALGONQUIN PWR & UTILITY - AQNCN 8.5321 07/01/2079 (AQNB). This can be considered as Overvalued.


How profitable is ALGONQUIN PWR & UTILITY - AQNCN 8.5321 07/01/2079 (AQNB) stock?

ALGONQUIN PWR & UTILITY - AQNCN 8.5321 07/01/2079 (AQNB) has a profitability rating of 3 / 10.


How financially healthy is ALGONQUIN PWR & UTILITY - AQNCN 8.5321 07/01/2079?

The financial health rating of ALGONQUIN PWR & UTILITY - AQNCN 8.5321 07/01/2079 (AQNB) is 4 / 10.


Can you provide the dividend sustainability for AQNB stock?

The dividend rating of ALGONQUIN PWR & UTILITY - AQNCN 8.5321 07/01/2079 (AQNB) is 6 / 10 and the dividend payout ratio is -569.86%.